Last reviewed · How we verify
A Double-Blind, Crossover Trial of Aricept® in Memory-Impaired Patients With Multiple Sclerosis: A Phase IV Demonstration of Functional MRI (fMRI) as a Surrogate Marker of Brain Activity Associated With Improvement in Memory Function
The purpose of this study is to determine if medication designed to improve memory will help patients with Multiple Sclerosis (MS) who are experiencing memory problems using fMRI to track brain activity.
Details
| Lead sponsor | Neurognostics |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 26 |
| Start date | 2004-09 |
| Completion | 2007-10 |
Conditions
- Relapsing-Remitting Multiple Sclerosis
Interventions
- Donepezil HCI (drug)
Primary outcomes
- Anatomic relationships during cognitive activity, and how these relationships change as a function of drug
Countries
United States